Legal Opinion
Zeneca, Inc. v. Shalala
Court of Appeals for the Fourth Circuit
Decided May 17, 2000No. 99-2329PublishedCited by 21 opinions
1Opinion of the Court
Affirmed by published opinion. Senior Judge HAMILTON wrote the opinion, in which Judge NIEMEYER and Senior Judge MINER joined.
OPINION
HAMILTON, Senior Circuit Judge.
This case involves a challenge by appellant Zeneca, Inc. (Zeneca), the manufacturer of the prescription drug DIPRIVAN, to the Food and Drug Administration’s (the FDA) approval of a generic version of DIPRIVAN manufactured by intervenor-appellee Gensia Sicor Pharmaceuticals, Inc. (Gensia). The district court granted Gensia’s and the FDA’s motions for summary judgment. Because we agree with the district court that the FDA’s approval…
2Cases cited8 opinions
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Baltimore Gas & Electric Co. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1983
- In Re Barr Laboratories, Inc.Court of Appeals for the D.C. Circuit · 1991
- Mova Pharmaceutical Corp. v. ShalalaCourt of Appeals for the D.C. Circuit · 1998
- MD Pharmaceutical, Inc. v. Drug Enforcement AdministrationCourt of Appeals for the D.C. Circuit · 1998
3 more not listed; retrieve them via the Exa API.
3Cited by21 opinions
- Audubon Naturalist Society of the Central Atlantic States, Inc. v. United States Department of TransportationDistrict Court, D. Maryland · 2007
- Astellas Pharma US, Inc. v. Food & Drug AdministrationDistrict Court, District of Columbia · 2009
- Dist. of Columbia v. TrumpDistrict Court, D. Maryland · 2018
- Sigma-Tau Pharmaceuticals, Inc. v. SchwetzCourt of Appeals for the Fourth Circuit · 2002
- Bell v. LollarIndiana Court of Appeals · 2003
16 more not listed; retrieve them via the Exa API.